Wilfred de Vega
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Wilfred Carlo de Vega, PhD, is a Business Development Specialist at Mitacs, Toronto, Canada. He completed his doctorate in the Department of Cell & Systems Biology at the University of Toronto, Canada, under the supervision of Dr. Patrick McGowan.
Doctorate thesis[edit | edit source]
- 2018, DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[1] - De Vega's thesis research, supervised by under the supervision of Dr. Patrick McGowan,[2] examined genome-wide epigenetic changes associated with ME/CFS and how these changes have downstream consequences on stress hormone sensitivity which could potentially relate to clinical subtypes based on symptom severity. His thesis work and ME/CFS research in the McGowan lab were funded by the Solve ME/CFS Initiative, Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Falk Medical Research Foundation. (Abstract) (Full Text)
[edit | edit source]
- 2014, DNA Methylation Modifications Associated with Chronic Fatigue Syndrome[3] (Full Text)
- 2017, Editorial - The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes[4] (Full Text)
- 2017, Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[5] (Full Text)
- 2018, Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome[6] (Abstract)
- 2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[7] (Abstract)
Talks and interviews[edit | edit source]
- 6 Oct 2016, MillionsMissing Canada Interview of Wilfred de Vega
- 4 May 2018, ME/CFS Canadian Collaborative Team Conference -The Epigenetic Landscape of ME/CFS: Deciphering Complex Phenotypes[8]
Online presence[edit | edit source]
Learn more[edit | edit source]
- Will de Vega: Man of the Moment in ME Research in Canada! by Jill T for Health Rising
- University of Toronto study offers hope sufferers chronic fatigue syndrome in U of T News
References[edit | edit source]
- ↑ de Vega, Wilfred Carlo (June 2018). "DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". TSpace - University of Toronto Libraries.
- ↑ "LinkedIn - Wilfred de Vega, PhD". July 2018.
- ↑ de Vega, Wilfred C.; Vernon, Suzanne D.; McGowan, Patrick O. (August 2014). "DNA Methylation Modifications Associated with Chronic Fatigue Syndrome". PLoS ONE. 9 (8): e104757. doi:10.1371/journal.pone.0104757.
- ↑ de Vega, Wilfred C.; McGowan, Patrick O. (2017), "The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes", Epigenomics, 9 (11), doi:10.2217/epi-2017-0106
- ↑ de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017), "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)", BMC Med Genomics, 10 (11), doi:10.1186/s12920-017-0248-3
- ↑ de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018), "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome", Epigenomics, 10 (5), doi:10.2217/epi-2017-0150
- ↑ Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (December 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769.
- ↑ "ME/CFS Canadian Collaborative Team Conference" (PDF). Retrieved March 11, 2019.
